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Abstract
Background:  Hypoglycaemia is a poor prognostic indicator in severe malaria. Intravenous
infusions are rarely feasible in rural areas. The efficacy of sublingual sugar (SLS) was assessed in a
pilot randomized controlled trial among hypoglycaemic children with severe malaria in Mali.
Methods:  Of 151 patients with presumed severe malaria, 23 children with blood glucose
concentrations < 60 mg/dl (< 3.3 mmol/l) were assigned randomly to receive either intravenous
10% glucose (IVG; n = 9) or sublingual sugar (SLS; n = 14). In SLS, a teaspoon of sugar, moistened
with a few drops of water, was gently placed under the tongue every 20 minutes. The child was put
in the recovery position. Blood glucose concentration (BGC) was measured every 5–10 minutes
for the first hour. All children were treated for malaria with intramuscular artemether. The primary
outcome measure was treatment response, defined as reaching a BGC of >= 3.3 mmol/l (60 mg/
dl) within 40 minutes after admission. Secondary outcome measures were early treatment
response at 20 minutes, relapse (early and late), maximal BGC gain (CGmax), and treatment delay.
Results: There was no significant difference between the groups in the primary outcome measure.
Treatment response occurred in 71% and 67% for SLS and IVG, respectively. Among the
responders, relapses occurred in 30% on SLS at 40 minutes and in 17% on IVG at 20 minutes. There
was one fatality in each group. Treatment failures in the SLS group were related to children with
clenched teeth or swallowing the sugar, whereas in the IVG group, they were due to unavoidable
delays in beginning an infusion (median time 17.5 min (range 3–40).
Among SLS, the BGC increase was rapid among the nine patients who really kept the sugar
sublingually. All but one increased their BGC by 10 minutes with a mean gain of 44 mg/dl (95%CI:
20.5–63.4).
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Conclusion: Sublingual sugar appears to be a child-friendly, well-tolerated and effective promising
method of raising blood glucose in severely ill children. More frequent repeated doses are needed
to prevent relapse. Children should be monitored for early swallowing which leads to delayed
absorption, and in this case another dose of sugar should be given. Sublingual sugar could be
proposed as an immediate "first aid" measure while awaiting intravenous glucose. In many cases it
may avert the need for intravenous glucose.
Background
Hypoglycaemia is common in tropical paediatrics [1] and
is a poor prognostic indicator in severe malaria [2-4]. It
often remains undetected in severely ill children. In Africa,
many children with hypoglycaemia and severe malaria die
before reaching a health care facility where intravenous
treatment is available [5]. Intravenous infusions are rarely
feasible in rural Africa because of the lack of simple equip-
ment or trained staff and can be difficult to administer in
young children[6]. Although intravenous infusions are
not supposed to be given outside of secondary care set-
tings, in practice they sometimes are (and sometimes
abused or given unsafely [7]).
An alternative route of administration is via the sublin-
gual mucosa and it is possible to give simple sugar rather
than glucose, as shown previously among moderately
hypoglycaemic children [8,9]. Sugar is degraded in the
oral cavity by sucrase [10], then glucose is transported
through the oral mucosa [11]; the transport system is
more abundant under the tongue than in the buccal cavity
[12]. This was a pilot study to assess the efficacy of sublin-
gual sugar (SLS) in a randomized controlled trial among
hypoglycaemic children with presumed severe malaria.
Methods
Setting
The study was conducted in the Paediatric Department of
Sikasso Regional Hospital, in Southern Mali, during the
peak malaria season (July – September 2006). All patients
presenting with presumed severe malaria were screened
for inclusion.
This 20-bed paediatric ward is staffed by one Malian con-
sultant paediatrician (ED), two foreign doctors (Chinese
and Cuban, neither of whom is a paediatrician), two or
three interns, and six members of nursing staff (only one
of whom is a fully qualified nurse). Out of hours there is
one intern and one member of nursing staff on duty.
There are 150–200 admissions per month during the peak
malaria season, the majority with a presumed diagnosis of
severe malaria. Case fatality rates prior to our study aver-
aged 14–19% during these months [13].
Participants
Children were eligible if they were aged 6 months to 15
years, met the WHO case definition of severe malaria [4],
had seizures or were prostrated or in coma, had blood glu-
cose concentration (BGC) < 60 mg/dl (< 3.3 mmol/l), and
families gave oral and written informed consent. Children
who required intravenous infusions for other reasons
(treatment of shock, acidosis, transfusion) were not eligi-
ble.
Children were included in the analysis if sufficient blood
glucose measurements were available to assign an out-
come. Participants were randomised to receive sublingual
sugar (SLS) or intravenous glucose (IVG), according to a
pre-established randomisation list. Allocation was not
concealed. Once the child was considered to comply with
the inclusion criteria, s/he was allocated according to the
randomised list under the supervision of the team.
Interventions
The SLS group received a teaspoon of sugar (level tea-
spoon for those under 15 kilos, heaped teaspoon for those
above that weight, which approximates to 2.5 g and 3.5 g
of sugar, respectively) moistened with water placed under
the tongue. Ordinary granulated sugar was used, bought
from the local market. Treatment was repeated every 20
minutes and continued for two hours. After placing sugar
under the tongue, children were placed in the recovery
position to prevent inhalation. Furthermore, regular
checks were made to see whether the sugar had been swal-
lowed. SLS children who did not increase their BGC by 20
minutes or normalize their blood glucose by 40 minutes
were switched to intravenous glucose.
The IVG group received 5 ml/kg 10% glucose intravenous
infusion as soon as was practically possible. Conditions
were artificially improved for provision of intravenous
glucose. All the necessary equipment was provided free
and was available for immediate use in the emergency
room. All children were treated for malaria with intramus-
cular artemether. No patient was treated with quinine.
Laboratory measurements
Before enrolment, 0.1 ml of blood was collected through
finger prick to measure the baseline blood-glucose con-
centration (BGC). This was repeated every five minutes for
20 minutes, then every 10 minutes (Ascensia Esprit and
Breeze glucometers, Bayer Diagnostics, precision of 1 mg/
dl). Results were recorded in mg/dl (these can be con-
verted to mmol/l, by dividing the result by 18: for exam-Malaria Journal 2008, 7:242 http://www.malariajournal.com/content/7/1/242
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ple, 60 mg/dl = 3.3 mmol/l, 54 mg/dl = 3.0 mmol/l and
40 mg/dl = 2.2 mmol/L.
A thick film for malaria parasites was prepared and read
afterwards. The definition of hypoglycemia was derived
from standard paediatric textbooks: a blood glucose con-
centration < 60 mg/dl (< 3.3 mmol/L) was considered
abnormally low and defined the hypoglycaemic
group[14,15].
Outcome measurements
One primary and four secondary outcome measurements
were used.
The primary outcome was the treatment response rate,
defined as reaching a glucose concentration over 60 mg/dl
during the first 40 minutes. The following secondary out-
comes were evaluated with the same method in both
groups:
i) Early treatment response was defined as a significant
blood glucose gain (> 10 mg/dl) at or before 20 minutes
ii) Relapse was defined as children who reached a normal
glycaemia 3.3 mmol/L (60 mg/dl), but failed to maintain
it during the study period defining early or late relapse
(before 20 or after 20 minutes).
iii) The maximal BGC gain (CGmax) was defined as the
difference between baseline BGC and the peak glucose
concentration (on the first-line treatment) within the first
40 minutes.
iv) The treatment delay was the time from confirmation of
hypoglycaemia to the beginning of treatment
Statistical analysis
Analysis was performed on intention to treat. Data were
entered in Epi-Info (version 6.04, CDC Atlanta). Since the
interval between two BGC measurements was very short,
some values were missing, they were treated as missing
values. Hypoglycaemia over time was analysed according
to the route of administration. Analysis was carried out by
STATA, versions 8 (Stata Corporation, College Station, TX,
USA). Fisher's exact tests were used for categorical varia-
bles, Student's t test for normally distributed continuous
data, and Mann-Whitney test when appropriate. Probabil-
ity values of < 0.05 were regarded as statistically signifi-
cant. Results were expressed as mean and 95% confidence
interval (95%CI) or median time and range as appropri-
ate.
Ethical considerations
The study was approved by the National Ethical Review
Board of Mali. All patients' parents gave informed oral
consent before being included in the study, which was
then followed up with written consent. The study was per-
formed in accordance with the Declaration of Helsinki
[16].
Results
Of 151 patients with presumed severe malaria between
August and September 2006, 26 children (14 SLS, 12 IVG)
met the inclusion criteria. Three IVG children were not
tested for glycaemia during the follow-up due to a misun-
derstanding, (initially some staff thought that serial BGC
measurements were only needed for patients on SLS),
resulting in BGC data being available for 14 SLS and 9
IVG. These are the patients described in the analysis
below.
Baseline characteristics are shown in Table 1. There was no
clinically significant difference in the patients' characteris-
tics between groups, except that there were more coma-
tose children on IVG (p = 0.06).
Table 2 shows the outcomes by intention to treat analysis.
There is no significant difference in the primary outcome
measure between the groups. In the secondary outcome
measures, there were more relapses in the SLS group, and
treatment delay was much longer in the IVG group. There
were no significant differences in the other secondary out-
come measures. Only 2 SLS children were switched to an
intravenous infusion within the 40 minutes after observed
early swallowing and early failure at 20 minutes.
About one-third of children had treatment failure in both
groups. Treatment failures in the SLS group were related to
children with clenched teeth or swallowing the sugar,
whereas in the IVG group, they were due to unavoidable
delays in beginning an infusion (median time 17.5 min
(range 3–40).
The BGC increase was rapid in the SLS group with an over-
all mean gain of 36 mg/dl (95%CI:17.6–54.5) by 10 min-
utes. 8/14 (57%) increased their BGC significantly by 10
minutes (> 10 mg/dl). 9/14 (64%) had a BGC > 60 mg/dl
by 20 minutes.
Relapse was more frequent in SLS group (30%). In the
IVG group, there was one relapse at 20 minutes (BCG: 31
mg/dl) due to a blocked infusion, but the BGC had
increased to 69 mg/dl by 40 minutes.
During close monitoring, four children on SLS were
detected to have swallowed the sugar rather than having
kept it under their tongue. They had a slower BGC
increase and two failed to reach 60 mg/dl at 40 minutes.
They were given intravenous glucose (two at 20 minutes,
two at 40 minutes). In contrast, eight of the nine patientsMalaria Journal 2008, 7:242 http://www.malariajournal.com/content/7/1/242
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who really kept the sugar sublingually increased their
BGC during the follow-up. In this subgroup, all but one
increased their BGC by 10 minutes, with a mean gain of
44 mg/dl (95%CI: 20.5–63.4). Figure 1 illustrates the
speed with which BGC was corrected.
Glycaemia was slower to increase in IVG than in SLS, tak-
ing the start time as diagnosis of hypoglycaemia. Only
four infusions were started in less than 10 minutes. The
median time to begin an infusion was 17.5 minutes. Once
the infusion was sited, BGC increased rapidly in all chil-
dren in less than five minutes. One infusion
became blocked after 15 minutes and the BGC dropped to
31 mg/dl.
SLS was well tolerated and no child developed any cough
or symptoms suggesting inhalation. SLS was painless and
easy to use in all children except for one with trismus.
Discussion
This pilot study in a Malian district hospital reports the
effect over a 40 minute period of two administrations of
sublingual sugar in young children (< 5 years of age) with
severe malaria and BGC below 60 mg/dl (3.3 mmol/l).
This administration was compared with the standardised
intravenous infusion of 10% glucose. Results were similar
in both groups. Overall 71% of the SLS reached a BGC
over 60 mg/dl within 40 minutes and 64% within 20 min-
utes. SLS resulted in a rapid correction of BGC; among
Table 1: Characteristics of hypoglycaemic children (BGC < 60 mg/dl) on admission to Sikasso paediatric ward
Sublingual Sugar (SLS)
n = 14
(95%CI)
Intravenous Glucose (IVG)
n = 9
(95%CI)
Sex (% F) 29 44
Mean age (months) 26.7 (19.8–33.7) 34.3 (5.8–62.8)
Mean weight (kg) 10.8 (9.4–12.7) 10.1 (6.9–13.1)
Duration of illness before presentation (days) 2.55 (1.4–4.1) 2.79 (1.8–3.1)
Coma£ 2 (14%) 5 (56%)
Prostration (%) 12 (86%) 7 (78%)
Convulsions (%) 3 (21%) 1 (11%)
Respiratory distress (%) 7 (50%) 5 (56%)
Splenomegaly (%) 4 (29%) 4 (44%)
Malnutrition (%)* 1 (7%) 0
Mean temperature °C 38.9 (38.3–39.3) 38.3 (37.2–39.3)
Mean glycaemia (mg/dl) 46.5 (40.7–52.2) 45.0 (36.0–53.9)
Number of children with BGC < 40 mg/dl (< 2.2 mmol/l) 3 (21%) 2 (22%)
Number of children with BGC < 54 mg/dl (< 3.0 mml/L) 10 (71%) 6 (79%)
Thick film positive for P. falciparum (%) 11 (79%) 8 (89%)
£ p = 0.06, The mean blood glucose was 50.0 and 47.6 mg/dl in the comatose children in groups SLS and IVG, respectively.
* underweight: weight for age below 2 standard deviation
Table 2: Intention to treat analysis: Clinical and biological responses to IV glucose or sublingual sugar administration among children 
with hypoglycaemia (BGC < 60 mg/dl) in Mali
Sublingual Sugar (SLS) Intravenous Glucose (IVG) p
n = 14
(95%CI)
n = 9
(95%CI)
Primary Outcome measure
- Treatment Response (reaching 60 mg within 40 minutes) 10/14 (71%) 6/9 (67%) 0.81
Secondary outcome measures
- Early treatment responsea 9/14 (64.3%) 6/9 (67%) 0.91
- Relapseb (as % of treatment responders) 3/10 (30%) 1/6 (17%) 0.55
-CGmaxd(mg/dl) 43.4 (25.8–62.5) 46.2 (19.1–73.2) 0.60
-Treatment delay (mins)e < 5 18.9 (6.4–31.6) -
Case Fatality 1 (7%) 1 (11%) NS
a defined as a significant blood glucose gain (> 10 mg/dl) at or before 20 minutes
b defined as children who reached a normal glycaemia 3.3 mmol/L (60 mg/dl), but failed to maintain it
c defined as the difference between baseline BGC and the peak glucose concentration (on the first-line treatment) within the first 40 minutes
d the time from confirmation of hypoglycaemia to the beginning of treatment. Treatment delay for SLS was always less than 5 minutes and was not 
recorded precisely so 5 minutes was taken as a conservative estimate; for IVG, treatment delay was the observed value.Malaria Journal 2008, 7:242 http://www.malariajournal.com/content/7/1/242
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nine children who really kept the sugar sublingually, all
but one increased their BGC within 10 minutes of sublin-
gual sugar administration with a mean gain of 44 mg/dl.
These results suggest the efficacy of SLS for the rapid cor-
rection of hypoglycaemia, but also the need for more fre-
quent and repeated administration as objectified by the
30% relapse rate at 40 minutes before the third adminis-
tration of sugar. The number and interval of repeated
sugar doses needed to obtain a steady BGC requires fur-
ther study over a longer duration, and with more patients.
The results of this study with children with BGC < 60 mg/
dl give important information to allow a further study in
children with more severe hypoglycaemia (e.g. < 40 mg/
dl) and comatose children who stand to benefit more
from such a treatment.
This study suggests that sublingual sugar is almost cer-
tainly better than no treatment because no significant gain
in glycaemia was seen in patients in the IVG group before
the intravenous infusion of glucose was started (and it
would be unethical to include a no treatment arm in any
study of hypoglycaemia in severe malaria). Therefore sub-
lingual sugar can be recommended in situations where the
gold standard treatment of intravenous glucose is not
immediately available.
Hypoglycaemia is particularly common in children with
falciparum malaria who are younger than three years of
age [4,17,18]. This feature of severe malaria is associated
with a three- to ten-fold increase in case fatality [3,19,23].
Correction of hypoglycaemia is an important therapeutic
measure, although it is not clear whether this is sufficient
to improve the prognosis.
When intravenous infusions are not feasible, because of
lack of material or trained staff, which is the case in many
rural health centres, no alternative has yet been devel-
oped. Oral absorption is delayed until the sugar reaches
the duodenum [17] and may cause severe inhalation in
prostrated or comatose children. The oral mucosa and the
sublingual cavity offer a relatively unexplored alternative
[8] though degradation of sucrose and a transport system
of sucrose has been shown in the dorsal part of the tongue
[11,12]. The previous study conducted in Burkina Faso in
children with low glycaemia confirmed that SLS was more
rapidly absorbed than oral sugar [8]. It also suggested the
need for repeated administration and gave preliminary
information on the interval doses for sugar administra-
tion. Further evaluation is needed to determine whether
the interval can be decreased between administrations of
sugar, which may enhance the efficacy of the SLS. Absorp-
tion appeared to be effective within the 10 first minutes in
the present Malian study.
Compared to the previous study [6], the treatment failure
and early failure rates were greater, but the CGmax was the
same (46 mg/dl). This may be explained by the lower ini-
tial glycaemia of children in this study, their younger age
and their more severe disease.
As in Burkina Faso SLS was well tolerated, painless and
easy to use, no inhalation was reported. The feasibility
was good with only one failure due to trismus. SLS
appeared to be a child-friendly method.
Various definitions of hypoglycemic blood sugar levels for
infants and children have been reported and remain con-
troversial [20,21]. For severe malaria a cut-off of 2.2
mmol/L (40 mg/dl) is widely used but other thresholds
have also been used: 41, 48, and 54 mg/dl [4,17,22,23].
The definition of standard paediatric reference texts was
used in this study: the normal serum glucose concentra-
tion for children beyond the newborn period is greater
than or equal to 60 mg/dl (3.3 mmol/L) [14,15]. In fact,
the 3.0 mmol/L (54 mg/dl) cut-off could have been used
with very similar results, since five children had a BGC of
55 mg/dl and two had a BGC of 57 mg/dl, with an equal
distribution between both groups.
Interestingly, with sublingual sugar, the correction of
hypoglycaemia tended to occur faster than with intrave-
nous glucose because there are inevitable delays in setting
up the infusion, as it is often difficult to find a vein in a
small, unconscious and shocked child. Four early failures
at 20 minutes were observed due to delays in the IVG
group.
As in many West African hospitals, intra-osseous infu-
sions are not available to avoid this delay. This should be
an important improvement at the district level in the
future if the necessary equipment, hygienic conditions
and trained staff are available.
Mean blood glucose concentration in the sublingual (SLS) and  dextrose infusion groups (IVG), by intention to treat Figure 1
Mean blood glucose concentration in the sublingual 
(SLS) and dextrose infusion groups (IVG), by inten-
tion to treat.
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In this study results for IVG were artificially good, because
all the equipment was made immediately available at the
point of need, and free-of-charge. The normal situation in
the hospital is that the patient's parents are given a pre-
scription for the bag of intravenous glucose, the intrave-
nous catheter, the administration set and any other
necessary medications. They must then go and purchase
this from the pharmacy, and bring it back to the ward
before treatment can commence. This can introduce
severe delays if the parent has to go and find or borrow the
money, or if the pharmacy is out-of-stock of one or more
items, which is not an infrequent occurrence. The advan-
tage of sublingual sugar is that it is virtually free, immedi-
ately available, and does not require a prescription or a
pharmacy. Furthermore, it is also available everywhere,
including peripheral health centres and villages, where
intravenous glucose is not available.
This study may have important implications for the clini-
cal management of malaria in children with a potential
risk of hypoglycaemia in the field. SLS could be used as a
preventive intervention at home, but also at the health
centre. In fact, use of SLS was rapidly adopted by the com-
munity in Sikasso region before and during referral of
children. A community-based study could evaluate the
impact of such a recommendation on the prevalence of
hypoglycaemia and mortality of children admitted to hos-
pital.
Limitations
This study was performed in the field conditions of a busy
West African paediatric ward, during the malaria season,
which explains some of its limitations (the small sample
size and the incomplete data for some patients).
In the SLS group, the number of comatose children was
small and lower than in the IVG group (table 1). Most
children had other features of severe malaria with respira-
tory distress, prostration and convulsions. Children in
coma are the most likely to benefit from SLS administra-
tion and these preliminary results need to be confirmed in
a larger scale study of comatose children.
The sublingual sugar administration has two main limita-
tions. Firstly, at least 29% of the children swallowed the
sugar rather than keeping it under the tongue (particularly
children in a less severe state and hence able to swallow).
The oral route has a slower absorption in the duodenum
and is slower to normalize glycaemia [17]. Early swallow-
ing may remain undetected by busy staff who have to be
trained to detect this. When sugar is swallowed before 10
minutes, another SLS administration should be recom-
mended. The non-responsive child on SLS may have swal-
lowed the sugar undetected by the team. He received an
infusion after 40 minutes so it is impossible to know
whether he had delayed oral absorption. Secondly, the
small volume of the sublingual cavity limits the SLS dose
available and may restrict SLS to young children. Children
were below five years of age and the SLS doses were satis-
factory. However, this is the age group at greatest risk of
severe malaria in Africa. The initial mean single SLS dose
was 0.25 g/kg (95%CI: 0.20–1.28), which is below the
recommended dose (0.5 g/kg). This implies the need to
frequently repeat the SLS doses [7], in order to avoid
relapses.
The limited duration time of the study only allowed eval-
uation of two administrations of sugar (i.e 5–6 g), but 3
or 4 administrations would be needed to obtain a steady
BGC. Relapses at 40 minutes were observed after a rapid
initial increase of BGC and BGC should be monitored
until it remains stable [17] – or, when monitoring is
impossible, SLS administration should be repeated every
10–20 minutes (e.g. during the transport to hospital).
More studies with older children are necessary to see
whether the SLS route is also adequate for older ages and
how doses need to be adapted.
The aetiology of hypoglycaemia was presumed to be
malaria and the duration of illness prior to the admission.
However, the study did not enquire about other causes of
hypoglycaemia and it is not known whether some tradi-
tional antimalarials may cause hypoglycaemia.
Implications
Although the sample size is small, the results indicate suf-
ficient safety and efficacy to justify the use of sublingual
sugar at the community level and to justify a further larger
trial. Intravenous treatment is often considered the gold
standard. It may give a false sense of security when moni-
toring is not correct, which is often the case in remote set-
tings. One infusion was blocked at 15 minutes and the
child's BGC quickly dropped to a very low level.
In hospital, SLS can be recommended when infusions are
not immediately available (or until they are put in place)
or when a transfusion is urgently needed. In the case of
parallel blood transfusions (patients with anaemia and
hypoglycaemia), SLS carries a lower risk of fluid overload
than IVG, and as such might be useful even in well
resourced settings.
Conclusion
This preliminary study suggests that sublingual sugar is a
promising treatment for the prevention and correction of
hypoglycaemia in children with severe malaria. Our
results suggest that a more frequent repetition of doses is
needed to prevent relapse, for example every 10 minutes
instead of every 20 minutes. A larger study is needed to
evaluate the more frequent dosing, and to confirm thesePublish with BioMed Central    and   every 
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results. This treatment is feasible in most children, even if
comatose, as a "first-aid" measure by health care workers
and even families in remote areas. This may impact on
morbidity and mortality in children with hypoglycaemia,
not only linked to severe malaria but also to malnutrition
or intoxication, and has important implications for the
clinical management of children in tropical countries.
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95%CI: 95% confidence interval; SLS: sublingual sugar;
SLS: sublingual sugar group; BGC: blood glucose concen-
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grammes per decilitre; mmol/l: Millimoles per liter; g/kg:
Grammes per kilogramme.
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